David Egilman, Doctor Who Took On Drug Companies, Dies at 71news2024-04-15T21:59:12+00:00April 15th, 2024|The New York Times|
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Saysnews2024-04-04T12:18:29+00:00April 4th, 2024|The New York Times|
Centene Health Care Fraud Case: How Private Lawyers Profitednews2024-03-21T09:01:46+00:00March 21st, 2024|The New York Times|
Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pillnews2024-02-09T23:07:08+00:00February 9th, 2024|The New York Times|
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Upnews2023-12-06T11:59:57+00:00December 6th, 2023|The New York Times|
Rite Aid Files for Bankruptcy, Facing Slumping Sales and Opioid Suitsnews2023-10-16T06:05:18+00:00October 16th, 2023|The New York Times|
Drug Makers Agree to Negotiate With Medicare on Prices of 10 Medicationsnews2023-10-03T22:38:52+00:00October 3rd, 2023|The New York Times|
Supporters of Aid in Dying Sue N.J. Over Residency Requirementnews2023-09-16T09:02:08+00:00September 16th, 2023|The New York Times|
Justice Dept. Asks Supreme Court to Hear Abortion Pill Casenews2023-09-08T23:06:10+00:00September 8th, 2023|The New York Times|
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billionnews2023-08-23T20:33:07+00:00August 23rd, 2023|The New York Times|